OpenResearchAlpha

JAMA Cardiology · 11 Nov 2026

Assessment of Coronary Inflammatory Risk From Noncontrast Cardiac Computed Tomography

Kenneth Chan, Mark Colin Gissler, Ikboljon Sobirov, Elizabeth Wahome, Pete Tomlins, Laura V. Klüner, Evangelos K. Oikonomou, Edward Nicol, Jonathan Weir-McCall, Ronak Rajani, David Adlam, Jonathan Rodrigues, Nicholas Screaton, Attila Kardos, John P. Greenwood, Nikant Sabharwal, Andrew Kelion, Francesca Pugliese, Steffen E. Petersen, Vinoda Sharma, Vijay Kunadian, Timothy Fairbairn, Leanne Eveson, Michael Petrus, Stavros Spyropoulos, Christos P. Kotanidis, Alexios S. Antonopoulos, Chris Mathers, Muhammad Siddique, Sam Fry, Parijat Patel, Henry West, Ahmad Abdullrahman, Damaris Darby, Yogesh Sohan, Cheerag Shirodaria, Brittany Weber, Daniel Huck, Ron Blankstein, Nehal N. Mehta, Milind Desai, Bernard J. Gersh, Stephan Achenbach, Peter Libbyh-index 53, Stefan Neubauer, Keith M. Channon, John Deanfield, Charalambos Antoniades, ORFAN Consortium, Sheena Thomas, Jon Denton, Robyn Farrall, Leon Dong, Athanasia Panopoulou, Karolina Rehakova, Mary Kasongo, Victoria Pettitt, Andy Marfleet, Chrisha Ledesma, Cheng Xie, Bruno Silva Santos, Michail C Mavrogiannis, Susan Anthony, Adrian Banning, Rafail A Kotronias, Tarun K Mittal, Anne Rose, George Hudson, Amrita Bajaj, Intrajeet Das, Aparna Deshpande, Praveen Rao, Dan Lawday, Saeed Mirsadraee, Benjamin Hudson, John Graby, David Murphy, Colin Berry, Mohamed Marwan, Pál Maurovich-Horvat, Guo-Wei He, Wen-Hua Lin, Li-Juan Fan, Naohiko Takahashi, Hidekazu Kondo, Neng Dai, Junbo Ge, Bon-Kwon Koo, Marco Guglielmo, Gianluca Pontone, Theodora Benedek, Dijana Vilic, Haleema Aljazzaf, Mak S Mun, Giulia Benedetti, Rebecca L Preston, Zahra Raisi-Estabragh, Derek L Connolly, Rebecca Grenfell, William Bradlow, Matthias Schmitt, Fabiano Serfaty, Ilan Gottlieb, Mario FT Neves, David E Newby, Tomasz Guzik, Marc R Dweck, Guido Claessen, Stéphane Hatem, Louise Meyfroit, Alban Redheuil, Georgios Benetos, Meinrad Beer, Gastón A Rodriguez-Granillo, Joseph Selvanayagam, Francisco Lopez-Jimenez, Ruben De Bosscher, Alain Tavildari, Gemma Figtree, Stuart Michael Grieve, Ibrahim Danad, Ronney Shantouf, Bas Kietselaer, Dimitris Tousoulis, George Dangas, Leslee Shaw, Shahzad Munir, Elisa McAlindon, Marly Van Assen, Filippo Crea, Giulia La Vecchia, Stephen A. Bloom, Vasvi Singh, Nick Ho, Wang Dee Dee, Carl E. Orringer, Todd Villines, Jessica Lee, Lora Nordstrom, Claudia Islas, Erika Hutt, Hsiang-Chun Lee, Simon Winther, Nikolaos Kadoglou, Thijs Eijsvogels, Thijs Schrama, Vincent Aengevaeren

0
Citations
no database records one yet
0
Citations in 2026
so far
53
Leading author's h-index
Peter Libby, in QAI's scholar index
31
References
works it cites, from open citation data

Citations by database

Each database indexes a different set of journals, preprints and books, so they are shown side by side rather than blended.

  • OpenCitations0
  • Crossref0
  • Europe PMC0

Citations per year

The current year is still counting.

  • 2026 so far0

Abstract

Importance Individuals with low or minimal coronary artery calcification (CAC) are considered at low cardiovascular risk, but a substantial absolute number of cardiovascular events occur in this population; assessment of coronary inflammation using the fat attenuation index (FAI) score may identify residual inflammatory risk beyond CAC score. Objective To assess whether coronary inflammation measured on coronary computed tomography angiography (CCTA) or noncontrast cardiac CT (NCCT) identifies individuals at high cardiovascular risk independent of CAC burden. Design, Setting, and Participants In this cohort study, a novel artificial intelligence algorithm for measuring FAI score on NCCT was trained and tested in an independent, multicenter, longitudinal cohort of consecutive individuals undergoing clinically indicated CCTA and NCCT for CAC score between 2010 and 2021, with median (IQR) follow-up of 6.7 (4.6-10.0) years. Data were analyzed from January 2010 to March 2024. Exposure Agatston CAC score and coronary inflammation from both CCTA (CCTA FAI score, established biomarker) and NCCT (NC FAI score, novel biomarker). Main Outcomes and Measures The primary outcome was cardiovascular (CV) mortality; the secondary outcome was major adverse cardiovascular events (MACE), comprising myocardial infarction, new-onset heart failure, or CV death. Results The derivation cohort included 6818 individuals (median [IQR] age, 61 [51-71] years; 3543 female participants [52.0%]), and the external validation clinical outcomes cohort included 19 110 individuals (median [IQR] age, 56.0 [48.0-64.0] years; 9289 female participants [48.6%]). During follow-up, 536 CV deaths and 1727 MACE occurred. FAI scores independently stratified CV mortality risk across CAC score categories, with the strongest associations among individuals with CAC score of 0. Adding CCTA FAI score or NC FAI score to CAC score significantly improved risk discrimination (area under the curve increased from 0.76 to 0.81 and 0.80, respectively; P < .001), reclassification (net reclassification index), and net benefit across all risk thresholds. Among 89 CV deaths in individuals with CAC score of 0 and 138 CV deaths with CAC score of 1 through 99, 44.9% and 44.2% had NC FAI score above the 75th percentile, respectively. Among individuals with CAC score of 0, CV mortality rates increased from 1.4 to 4.0 per 1000 person-years for those with NC FAI score above the 75th percentile, and MACE rates increased from 5.9 to 13.3 per 1000 person-years. Conclusions and Relevance Per the results of this cohort study, NC FAI score provides prognostic performance comparable to CCTA FAI score and improves cardiovascular risk prediction and reclassification beyond CAC score. Elevated FAI score, derived from either CCTA or NCCT, should be interpreted as a risk-enhancing factor that may prompt intensification of established, evidence-based preventive measures and may serve as a potential future gatekeeper for the use of targeted anti-inflammatory treatments.

What the data shows

  • No database records a citation yet, as is usual for a paper this new.
  • Peter Libby has the highest h-index among the authors (53).

Graph

This paper in the middle, its authors and their most-cited papers below, the papers it cites to the left and the papers citing it to the right. The timeline lays every paper out by year.

Citing paper shares an authorAuthor without a profileSize shows citations, or h-index for authors

Select a node for its details. Drag to pan, scroll to zoom, drag a node to move it.

Start with

Authors (147)

Each author's standing in QAI's scholar index: the works their ORCID iD is attached to, and for anyone whose ORCID record names a lab OpenResearch follows, their arXiv preprints matched by name and a shared co-author. Names are as printed on the paper.

ProfileMost-cited paper

Cited by 0 papers

Who cites this paper, from open citation data, with Crossref's record of each; the 100 newest when there are more.

0 shown
No citing papers for this filter.

References (31)

What it cites, from open citation data, with Crossref's record of each.

Sign in to see 11 more references

A free account opens the rest of the citing papers and references on every paper’s page.